DiaSorin S.p.A. (DSRLF)
DSRLF Stock Price Chart
Explore DiaSorin S.p.A. interactive price chart. Choose custom timeframes to analyze DSRLF price movements and trends.
DSRLF Company Profile
Discover essential business fundamentals and corporate details for DiaSorin S.p.A. (DSRLF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
11 Sept 2009
Employees
3.25K
Website
https://diasoringroup.comCEO
Carlo Rosa
Description
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIAISON XL, and LIAISON XL LAS; and molecular diagnostics platform comprising of LIAISON MDX for use in the amplification of nucleic acids to diagnose viral infections through the identification of virus in patient's biological sample. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.
DSRLF Financial Timeline
Browse a chronological timeline of DiaSorin S.p.A. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 May 2026
Upcoming earnings on 2 Mar 2026
Upcoming earnings on 3 Nov 2025
Earnings released on 31 Jul 2025
EPS came in at $0.88 , while revenue for the quarter reached $306.27M , beating expectations by +4.01%.
Earnings released on 6 May 2025
EPS came in at $0.97 , while revenue for the quarter reached $313.00M , beating expectations by +0.99%.
Dividend declared on 20 Mar 2025
A dividend of $1.35 per share was announced, adjusted to $1.41. The dividend was paid on 21 May 2025.
Earnings released on 14 Mar 2025
Earnings released on 5 Nov 2024
EPS came in at $0.84 .
Earnings released on 29 Jul 2024
EPS came in at $0.94 , while revenue for the quarter reached $300.21M , missing expectations by -52.09%.
Earnings released on 10 May 2024
EPS came in at $0.86 , while revenue for the quarter reached $289.00M .
Earnings released on 15 Mar 2024
EPS came in at $0.47 , while revenue for the quarter reached $270.00M .
Dividend declared on 15 Mar 2024
A dividend of $1.25 per share was announced, adjusted to $1.35. The dividend was paid on 22 May 2024.
Earnings released on 30 Dec 2023
EPS came in at $0.90 , while revenue for the quarter reached $302.21M .
Earnings released on 30 Jun 2023
EPS came in at $0.85 , while revenue for the quarter reached $286.79M .
Earnings released on 31 Mar 2023
EPS came in at $0.79 , while revenue for the quarter reached $289.60M , missing expectations by -53.73%.
Earnings released on 27 Mar 2023
EPS came in at $0.60 , while revenue for the quarter reached $348.84M .
Dividend declared on 27 Mar 2023
A dividend of $1.19 per share was announced, adjusted to $1.29. The dividend was paid on 24 May 2023.
Earnings released on 27 Oct 2022
EPS came in at $1.14 surpassing the estimated $0.90 by +26.67%, while revenue for the quarter reached $326.80M .
Earnings released on 3 Aug 2022
EPS came in at $1.04 falling short of the estimated $1.10 by -5.45%, while revenue for the quarter reached $327.84M , missing expectations by -52.89%.
Dividend declared on 19 May 2022
A dividend of $1.12 per share was announced, adjusted to $1.23. The dividend was paid on 25 May 2022.
Earnings released on 6 May 2022
EPS came in at $1.47 surpassing the estimated $1.14 by +28.95%, while revenue for the quarter reached $357.60M .
Earnings released on 16 Mar 2022
EPS came in at $1.42 surpassing the estimated $1.05 by +35.24%, while revenue for the quarter reached $378.75M , missing expectations by -50.78%.
Earnings released on 11 Nov 2021
EPS came in at $1.45 surpassing the estimated $1.22 by +18.85%, while revenue for the quarter reached $343.50M .
Earnings released on 30 Jul 2021
EPS came in at $1.31 falling short of the estimated $1.69 by -22.49%, while revenue for the quarter reached $248.70M , missing expectations by -59.52%.
Earnings released on 14 May 2021
EPS came in at $1.43 falling short of the estimated $1.51 by -5.30%, while revenue for the quarter reached $266.70M .
Dividend declared on 24 Mar 2021
A dividend of $1.22 per share was announced, adjusted to $1.17. The dividend was paid on 26 May 2021.
Earnings released on 11 Mar 2021
EPS came in at $1.56 surpassing the estimated $1.50 by +4.00%, while revenue for the quarter reached $271.21M .
Earnings released on 11 Nov 2020
EPS came in at $1.24 surpassing the estimated $0.94 by +31.91%, while revenue for the quarter reached $227.90M .
DSRLF Stock Performance
Access detailed DSRLF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.